计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
JBJ-09-063 TFA is a mutant-selective allosteric EGFR inhibitor with IC 50 s of 0.147 nM, 0.063 nM, 0.083 nM and 0.396 nM for EGFR L858R, EGFR L858R/T790M, EGFR L858R/T790M/C797S and EGFRLT/L747S. JBJ-09-063 TFA effectively reduces EGFR , Akt and ERK1/2 ph
Appearance:Solid
IC50& Target:EGFR L858R 0.147 nM (IC 50 ) EGFR L858R/T790M 0.063 nM (IC 50 ) EGFR L858R/T790M/C797S 0.083 nM (IC 50 ) EGFRLT/L747S 0.396 nM (IC 50 )
In Vitro:JBJ-09-063 is remarkably effective at inhibiting cell growth and leads to a significant increase in apoptosis, even though H3255GR cells are resistant to gefitinib as a single agent, as they contain an EGFR T790M mutation. JBJ-09-063 is effective in
In Vivo:JBJ-09-063 (3mg/kg i.v., 20mg/kg p.o.) exhibits favorable pharmacokinetics properties and is sufficiently stable to deliver good efficacy upon oral dosing. MCE has not independently confirmed the accuracy of these methods. They are for reference on
Biological Activity:JBJ-09-063 TFA is a mutant-selective allosteric EGFR inhibitor with IC 50 s of 0.147 nM, 0.063 nM, 0.083 nM and 0.396 nM for EGFR L858R, EGFR L858R/T790M, EGFR L858R/T790M/C797S and EGFRLT/L747S. JBJ-09-063 TFA effectively reduces EGFR , Akt and ERK1/2 ph